About healthcare quality and safety
Patient Photo on Health Record Curtails Medication Errors: The headline speaks for itself.
About pharma
Mylan and Biocon Launch Trastuzumab Biosimilar, Ogivri™ (trastuzumab-dkst), in the U.S.: This drug is a biosimilar to often-used breast cancer drug Herceptin.
About healthcare IT
A consumer-centered future of health: The findings are from Deloitte’s 2019 global health care consumer survey, focusing on consumer’s views of IT use. Among the findings:
“Increasing use of technology and willingness to share data: A growing number of consumers are using technology for measuring fitness, ordering prescription drug refills, and monitoring their health… Many consumers are willing to share their health data in various scenarios.
Interest in and use of virtual care: Consumers appear to be warming up to the idea of virtual health. More than half of those who have seen a care provider virtually report being satisfied and would likely have another virtual visit.
High levels of self-efficacy and prevention behaviors: People today seem more willing to tell their doctors when they disagree…
Use of tools to make decisions about prescriptions and care: Consumers are interested in using tools to compare pricing and for user reviews. This tends to be highest in countries where consumers have more exposure to out-of-pocket spending…
Interest in emerging technologies: Between 20 and 35 percent of people expressed interest in technologies leveraging robotics and artificial intelligence (AI) for health care, preventive care, monitoring, and caregiving.”